[一个哈雷尔-尤恩综合征病例,发作是由ATAD3A变体引起的]
概括
这份病例报告详细介绍了一名患有哈雷尔-尤恩综合征的年轻男孩,其特征是严重的发育迟缓和. 基因分析在ATAD3A基因中发现了一种致病变体,扩大了已知的临床谱.
科学领域:
- 遗传学 遗传学 是一个
- 神经学 神经学
- 儿科 儿科 儿科
背景情况:
- 哈雷尔-尤恩综合征是一种罕见的遗传性疾病.
- ATAD3A基因变异与神经发育障碍有关.
- 是哈雷尔-尤恩综合征的一个常见表现.
研究的目的:
- 报告一个中国儿童患有哈雷尔-综合征的新病例.
- 描述临床表型和遗传发现.
- 要突出ATAD3A变异的诊断和管理影响.
主要方法:
- 临床病例的介绍和评估.
- 使用吉塞尔发育表进行神经发育评估.
- 电脑电图 (EEG) 用于的表征.
- 整体外基因组测序用于遗传变异识别.
主要成果:
- 一个3岁10个月的男孩出现了全球发育迟缓,面部形,轴性低垂和耐火性.
- 脑电图显示了普遍的尖峰和尖峰和慢波放电.
- 在ATAD3A基因中发现了一种致病性新异构错误变异 (c.1582C>T,p.Arg528Trp).
- 抗发作药物可以控制发作,改善运动发育.
结论:
- 这是中国文献中关于哈雷尔-尤恩综合征与ATAD3A变体的首次报告.
- 鉴定到的ATAD3A变异扩大了该综合征已知的表型谱.
- 这个案例为诊断和管理ATAD3A相关疾病提供了宝贵的见解.
更多相关视频
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
9.0K
06:41In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
14.2K
相关概念视频
Seizures: Classification
1.3K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.3K
Epilepsy and Seizures: Overview
1.1K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
Antiepileptic Drugs: Potassium Channel Activators
603
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
603
Inborn Errors of Metabolism
681
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
681
Antiepileptic Drugs: Sodium Channel Blockers
1.5K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.5K
Antiepileptic Drugs: GABAergic Pathway Potentiators
1.2K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.2K
